These include those with LRRK2 mutations, who represent approximately 0.5–1.0% of unselected Parkinson disease cases in the general western communities, although considerably greater proportions of familial Parkinson disease or those of Ashkenazi Jewish origin. This evidence concerns the gene LRRK2 and Parkinson disease.